New drug could help thousands with chronic heart disease in England

New drug could help thousands with chronic heart disease in England A first-of-its-kind treatment targeting a chronic heart disease could offer a “greater hope” to thousands of people living with the condition.

The National Institute for Health and Care Excellence (Nice) has approved the use of mavacamten in draft guidance to the NHS. It would be used to treat those with obstructive hypertrophic cardiomyopathy (HCM), with about 7,000 people expected to benefit. The Guardian

See also:

• First treatment to target heart condition set to benefit thousands as NICE draft guidance approves NHS use National Institute for Health and Care Excellence